Athena Athena

X

Digital content for Longeveron

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Longeveron
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
1951 NW 7TH AVENUE SUITE 520 MIAMI, FL 33136
Telephone
Telephone
305.909.0840
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.globenewswire.com/news-release/2024/03/19/2848957/0/en/Longeveron-Announces-1-for-10-Reverse-Stock-Split.html

GLOBENEWSWIRE
19 Mar 2024

https://www.fiercebiotech.com/biotech/cash-runways-running-out-year-nicox-and-longeveron-plan-layoffs-and-narrow-focus

FIERCE BIOTECH
28 Feb 2024

https://www.globenewswire.com//news-release/2024/02/27/2836433/0/en/Longeveron-Reports-Year-End-2023-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
27 Feb 2024

https://www.globenewswire.com//news-release/2024/02/21/2833127/0/en/Longeveron-to-Report-Year-End-2023-Results-and-Provide-Corporate-Update-February-27-2024.html

GLOBENEWSWIRE
21 Feb 2024

https://www.globenewswire.com/news-release/2024/01/29/2818846/0/en/Longeveron-Receives-Notice-of-United-States-Patent-Allowance-for-the-Technology-Behind-its-Lead-Investigation-Product-Lomecel-B.html

GLOBENEWSWIRE
29 Jan 2024

https://www.globenewswire.com/news-release/2023/12/22/2800825/0/en/Longeveron-Announces-Closing-of-2-36-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html

GLOBENEWSWIRE
22 Dec 2023

https://www.globenewswire.com//news-release/2023/12/21/2800146/0/en/UPDATE-Longeveron-Announces-2-36-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html

GLOBENEWSWIRE
21 Dec 2023

https://www.globenewswire.com//news-release/2023/12/21/2799969/0/en/Longeveron-Announces-2-36-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html

GLOBENEWSWIRE
21 Dec 2023

https://www.globenewswire.com//news-release/2023/12/20/2799201/0/en/Longeveron-Announces-Additional-Positive-Clinical-Data-and-Imaging-Biomarker-Results-from-the-CLEAR-MIND-Phase-2a-Trial-of-Lomecel-B-in-the-Treatment-of-Mild-Alzheimer-s-Disease.html

GLOBENEWSWIRE
20 Dec 2023

https://www.globenewswire.com//news-release/2023/11/11/2778601/0/en/Long-term-Survival-Data-from-Longeveron-s-ELPIS-1-Trial-Presented-at-the-2023-Scientific-Sessions-of-the-American-Heart-Association.html

GLOBENEWSWIRE
11 Nov 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY